Indomethacin inhibits the natriuretic effects of neuropeptide Y in anesthetized rats

Neuropeptide Y (NPY) is a unique modulator of renal function that enhances urine flow and sodium excretion despite marked reductions in renal blood flow. We investigated whether the cyclooxygenase inhibitor indomethacin alters the renal NPY effects in anesthetized rats. Treatment with 5 mg/kg indomethacin i.p. lowered urinary prostaglandin excretion by approximately 85%. Systemic infusion of NPY elevated mean arterial pressure by approximately 15 mm Hg and renovascular resistance by approximately 8.0 mm Hg/ml/min, whereas the related peptide YY3-36 (PYY3-36) did not. Nevertheless, both peptides enhanced urine flow rate by approximately 250 and approximately 100 microl/15 min, respectively, and sodium excretion by approximately 15 micromol/15 min. Treatment with indomethacin did not affect NPY- and PYY3-36-induced alterations of systemic and renovascular hemodynamics but completely abolished NPY- and PYY3-36-induced diuresis and natriuresis. Endogenous creatinine clearance was not affected by any treatment. We conclude that cyclooxygenase-derived arachidonic acid metabolites are not involved in the systemic or renal hemodynamic effects of NPY and PYY3-36 but mediate NPY- and PYY3-36-induced diuresis and natriuresis.     

Hyoid bone malformation confirmed by 3-dimensional computed tomography

We describe the case of a young woman with pain on turning her head attributable to a malformation of the hyoid bone. Diagnosis was established using spiral computed tomography with the patient's neck in the position of greatest discomfort and with 3-dimensional reconstruction of the hyoid bone. Prior conventional radiography and magnetic resonance imaging did not aid in finding a diagnosis. After surgical removal of both greater cornua of the hyoid bone there was a complete relief of symptoms.     

All a RILEM technical recommendation should be

Editorial

All a RILEM technical recommendation should be     

Elimination of dislocations in heteroepitaxial MBE and RTCVD Ge x Si1-x grown on patterned Si substrates

We have grown Ge _x Si_1-x (0 <x < 0.20,1000–3000Å thick) on small growth areas etched in the Si substrate. Layers were grown using both molecular beam epitaxy (MBE) at 550° C and rapid thermal chemical vapor deposition (RTCVD) at 900° C. Electron beam induced current images (EBIC) (as well as defect etches and transmission electron microscopy) show that 2800Å-thick, MBE Ge_0.19Si_0.81 on 70-μm-wide mesas have zerothreading and nearly zero misfit dislocations. The Ge_0.19Si{0.81} grown on unpatterned, large areas is heavily dislocated. It is also evident from the images that heterogeneous nucleation of misfit dislocations is dominant in this composition range. 1000Å-thick, RTCVD Ge_0.14Si_0.86 films deposited on 70 μm-wide mesas are also nearly dislocation-free as shown by EBIC, whereas unpatterned areas are more heavily dislocated. Thus, despite the high growth temperatures, only heterogeneous nucleation of misfit dislocations occurs and patterning is still effective. Photoluminescence spectra from arrays of GeSi on Si mesas show that even when the interface dislocation density on the mesas is high, growth on small areas results in a lower dislocation density than growth on large areas.     

Filtering for bilinear systems with a lipschitz nonlinearity using LPV approach

This paper deals with the H _?? filtering problem for a class of nonlinear systems. This class of nonlinear systems is composed of a bilinear part and of a lipschitzian one. The use of an unbiasedness condition for the bilinear part (called quasi unbiasedness condition) permits to parameterize the filter matrices through a single gain. Two LPV (Linear Parameter Varying) extensions of the bounded real lemma are used to solve the filtering problem. This approach reduces the conservatism inherent to the boundedness of the inputs. Then the filtering solution is expressed in terms of LMI (Linear Matrix Inequality) to be verified at the vertices of a polytope. A numerical example is finally given to illustrate our approach.     

Microstructure and mechanical properties of modified and non-modified stir-cast Al-Si hypoeutectic alloys

The microstructure and mechanical properties of modified and non-modified stir-cast commercial aluminium alloys A-S7G03 and A-S4G have been investigated. Stir casting of these alloys resulted in spherical and/or rosette shape primary -phase, and the eutectic silicon was broken into miniature needle morphology. This stir-cast structure slightly improved the mechanical properties in comparison to those of conventionally cast alloys, however the fracture of the stir-cast alloys revealed intergranular brittle fracture. The addition of 0.02% strontium, in the form of Al-5 mass% Sr master alloy, during stir casting modified the eutectic silicon into a very fine spheroidal morphology, while the -phase particle showed the same morphology as the stir-cast alloys. This novel structure resulted in significant improvement of mechanical properties. The elongation of the modified stir-cast alloys was five times greater than that of the non-modified one. A transgranular mode of fracture was observed for the modified stircast alloys, moreover smooth ripple and dimple patterns were observed reflecting the high ductility of the modified stir-cast alloys.     

Oxidative dimerisation of propene to 1,5-hexadiene on Bi-Zn-O catalysts

The oxidative dimerisation of propene to 1,5-hexadiene has been investigated on Bi-Zn-O catalysts. The Bi₄₈ZnO₇₃ phase, observed in the catalysts calcined at 700 ° C is an active and selective catalyst for the formation of 1,5-hexadiene. The best catalytic performance (1,5-hexadiene selectivity 64%) has been obtained at 525 ° C, with a propene to oxygen ratio of 26, on a catalyst formed by Bi₄₈ZnO₇₃ with a small excess of ZnO.     

The correlation between the thermoelectric properties and stoichiometry in the boron carbide phase B4C-B10.5C

Electrical conductivity, thermoelectrical power and thermal conductivity measurements on boron carbide samples show that the electrical conductivity follows the small polaron hopping theory and that thermal conductivity occurs by phonon diffusion. The evolution of these properties with carbon content illustrates the particular role played by the 13.3 at% C compound in the phase homogeneity range B_10.5C to B₄C. The value of the figure of merit (0.85×10^–3 K at 1250 K) proves that this particular boron carbide compound could be a very interesting candidate material for high-temperature thermoelectrical conversion.     

Target Score—A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness

Esophageal cancer (EC) is a life-threatening disease, demanding the discovery of new biomarkers and molecular targets for precision oncology. Aberrantly glycosylated proteins hold tremendous potential towards this objective. In the current study, a series of esophageal squamous cell carcinomas (ESCC) and EC-derived circulating tumor cells (CTCs) were screened by immunoassays for the sialyl-Tn (STn) antigen, a glycan rarely expressed in healthy tissues and widely observed in aggressive gastrointestinal cancers. An ESCC cell model was glycoengineered to express STn and characterized in relation to cell proliferation and invasion in vitro. STn was found to be widely present in ESCC (70% of tumors) and in CTCs in 20% of patients, being associated with general recurrence and reduced survival. Furthermore, STn expression in ESCC cells increased invasion in vitro, while reducing cancer cells proliferation. In parallel, an ESCC mass spectrometry-based proteomics dataset, obtained from the PRIDE database, was comprehensively interrogated for abnormally glycosylated proteins. Data integration with the Target Score, an algorithm developed in-house, pinpointed the glucose transporter type 1 (GLUT1) as a biomarker of poor prognosis. GLUT1-STn glycoproteoforms were latter identified in tumor tissues in patients facing worst prognosis. Furthermore, healthy human tissues analysis suggested that STn glycosylation provided cancer specificity to GLUT1. In conclusion, STn is a biomarker of worst prognosis in EC and GLUT1-STn glycoforms may be used to increase its specificity on the stratification and targeting of aggressive ESCC forms.